drugset

drugset / Trial / NCT00022763

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

NCT00022763 ↗

Phase 2 Completed 52 enrolled Hoffmann-La Roche Trimeris · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will evaluate T-20 in children.

Timeline

Start: 2001-08
Primary completion: 2004-12
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Enfuvirtide	Peptide	—	—

Indications